We are delighted to announce the public release of Solstice V2. This is a landmark milestone for Injective and we are excited to share some exciting news with all of you.
Public Solstice V2 Testnet: Link
Solstice V2 Walkthrough: Link
On November 30, 2020, we released an early access version of the Solstice testnet.
Within one week we managed to compile feedback and release Solstice V2, which presents an unrivaled trading experience for everyone. We have managed to surpass every exchange in the market today, seamlessly integrating the best features from centralized exchanges while retaining a dynamic decentralized backend.
Some Initial Statistics from 10 days of the early access period
Number of Trades: 394,792
The trader with the Highest ROI: 1,029.2%
It should be noted that these statistics were generated during an early access period where we intentionally limited the number of users that were able to access the platform. This public release will likely eclipse these stats and aid in showcasing our dynamic throughput capabilities.
This launch marks the first time that we have had a full public release at Injective.
Over the weeks we have deployed a number of significant changes in order to create a heightened trading experience for everyone. This includes infrastructure and performance optimizations that have led to the creation of a much more robust platform.
In addition, the frontend UI changes were further upgraded to create a much more intuitive experience. We will introduce a number of other enhancements before the start of the upcoming trading competition.
The Solstice V2 public release marks the culmination of our team’s unparalleled ability to both execute and drive meaningful upgrades based on user feedback.
We can’t wait to see all of you on Solstice V2 as we continue to build the first fully decentralized derivatives exchange.
About Injective Protocol
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective Protocol is backed by a prominent group of stakeholders including Pantera Capital, one of the most renowned venture capital firms in the world, and the leading cryptocurrency exchange, Binance.